Mirault T - Search Results

1

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib.

Kim TD, Rea D, Schwarz M, Grille P, Nicolini FE, Rosti G, Levato L, Giles FJ, Dombret H, Mirault T, Labussière H, Lindhorst R, Haverkamp W, Buschmann I, Dörken B, le Coutre PD. Kim TD, et al. Among authors: mirault t. Leukemia. 2013 Jun;27(6):1316-21. doi: 10.1038/leu.2013.70. Epub 2013 Mar 5. Leukemia. 2013. PMID: 23459449

2

Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia.

Rea D, Mirault T, Raffoux E, Boissel N, Andreoli AL, Rousselot P, Dombret H, Messas E. Rea D, et al. Among authors: mirault t. Leukemia. 2015 May;29(5):1206-9. doi: 10.1038/leu.2014.342. Epub 2014 Dec 8. Leukemia. 2015. PMID: 25482133 No abstract available.

3

[Peripheral artery occlusive disease of the lower limbs: Rapid aggravation in a patient taking nilotinib for chronic myeloid leukemia].

Gautier V, Mirault T, Azarine A, Alsac JM, Sapoval M, Réa D, Messas E. Gautier V, et al. Among authors: mirault t. J Mal Vasc. 2015 Jul;40(4):231-9. doi: 10.1016/j.jmv.2015.05.006. Epub 2015 Jun 29. J Mal Vasc. 2015. PMID: 26139550 French.

4

[French Chronic Myeloid Leukemia Intergroup 2022 recommendations for managing the risk of cardiovascular events on ponatinib in chronic myeloid leukemia].

Réa D, Messas E, Mirault T, Nicolini FE. Réa D, et al. Among authors: mirault t. Bull Cancer. 2022 Jul-Aug;109(7-8):862-872. doi: 10.1016/j.bulcan.2022.04.003. Epub 2022 Jun 17. Bull Cancer. 2022. PMID: 35725593 French.

5

Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia.

Rea D, Mirault T, Cluzeau T, Gautier JF, Guilhot F, Dombret H, Messas E. Rea D, et al. Among authors: mirault t. Haematologica. 2014 Jul;99(7):1197-203. doi: 10.3324/haematol.2014.104075. Epub 2014 Mar 21. Haematologica. 2014. PMID: 24658819 Free PMC article.

6

Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome.

Mirault T, Rea D, Azarine A, Messas E. Mirault T, et al. Eur J Haematol. 2015 Apr;94(4):363-7. doi: 10.1111/ejh.12367. Epub 2014 Aug 23. Eur J Haematol. 2015. PMID: 24797802

7

[Takayasu arteritis].

Mirault T, Messas E. Mirault T, et al. Rev Med Interne. 2016 Apr;37(4):223-9. doi: 10.1016/j.revmed.2015.12.024. Epub 2016 Jan 27. Rev Med Interne. 2016. PMID: 26827273 Review. French.

8

[Aortitis].

Saadoun D, Messas E, Pouchot J, Mekinian A, Lambert M, Cacoub P, Mirault T. Saadoun D, et al. Among authors: mirault t. Rev Med Interne. 2016 Apr;37(4):221-2. doi: 10.1016/j.revmed.2015.12.020. Epub 2016 Jan 27. Rev Med Interne. 2016. PMID: 26827271 French. No abstract available.

9

[Recanalization procedure of the common femoral vein following iatrogenic femoral chronic occlusion: 3 cases].

Goudot G, Del Giudice C, Pellerin O, Courtois MC, Galloula A, Messas E, Mirault T, Sapoval M. Goudot G, et al. Among authors: mirault t. J Med Vasc. 2017 Jul;42(4):237-243. doi: 10.1016/j.jdmv.2017.05.002. Epub 2017 Jun 23. J Med Vasc. 2017. PMID: 28705343 French.

10

[Risk factors for recurrent venous thromboembolism].

Rosencher J, Mirault T, Martinez I, Zhu T, Messas E, Emmerich J. Rosencher J, et al. Among authors: mirault t. Rev Mal Respir. 2011 Apr;28(4):453-62. doi: 10.1016/j.rmr.2010.10.036. Epub 2011 Mar 21. Rev Mal Respir. 2011. PMID: 21549901 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters